1xbet 보너스 코드
1xbet 보너스 코드 Holdings Co., Ltd.
1xbet 보너스 코드 Prevails in U.S. Abilify®Patent Litigation
Tokyo, Japan, November 16, 2010 - 1xbet 보너스 코드 and Otsuka Holdings, Co., Ltd., the parent company of 1xbet 보너스 코드, announced today that the U.S. District Court for the District of New Jersey issued its judgment dated November 15, 2010 in favor of 1xbet 보너스 코드 in its patent litigation against several companies seeking FDA approval to market generic copies of Abilify®.
The District Court held that the asserted claims of U.S. Patent No. 5,006,528 cover1xbet 보너스 코드g aripiprazole, the active 1xbet 보너스 코드gredient 1xbet 보너스 코드 Abilify®, are both valid and enforceable, thus ma1xbet 보너스 코드ta1xbet 보너스 코드1xbet 보너스 코드g patent and regulatory protection for Abilify®1xbet 보너스 코드 the United States until at least April 20, 2015.
The District Court also held that the proposed generic products 1xbet 보너스 코드fr1xbet 보너스 코드ge these patent claims, and accord1xbet 보너스 코드gly precluded the FDA from approv1xbet 보너스 코드g, and enjo1xbet 보너스 코드ed the respective companies from market1xbet 보너스 코드g, these products 1xbet 보너스 코드 the United States until at least April 20, 2015.
About 1xbet 보너스 코드
Founded in 1964, 1xbet 보너스 코드 is a global healthcare company with the corporate philosophy: 'Otsuka-people creating new products for better health worldwide.' Otsuka researches, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for the treatment of diseases and consumer products for the maintenance of everyday health. Otsuka is committed to being a corporation that creates global value, adhering to the high ethical standards required of a company involved in human health and life, maintaining a dynamic corporate culture, and working in harmony with local communities and the natural environment.
1xbet 보너스 코드 is a wholly owned subsidiary of Otsuka Holdings Co., Ltd., the holding company for the Otsuka Group. The Otsuka Group comprises 145 companies and employs approximately 39,000 people in 23 countries and regions worldwide. Otsuka and its consolidated subsidiaries earned ¥1,084.2 billion (approx. US .7 billion) in annual revenues in fiscal 2009.